Wearable tech aims to boost sleep apnea treatment adherence

NCT ID NCT06039865

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether a program using a consumer wearable device—which tracks oxygen levels during sleep—along with personalized weekly reports can help adults with obstructive sleep apnea use their positive airway pressure (PAP) therapy more consistently. Participants who are not currently adhering to their PAP therapy will either receive the wearable program immediately or after a waiting period, during which they receive usual care. The study compares changes in PAP usage between the two groups over about five weeks to see if the wearable-based approach improves adherence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A consumer wearable device that measures oxygen levels during sleep, paired with customized weekly reports
What this could lead to
If effective, this wearable-based program could offer a simple, low-cost way to help people with sleep apnea stick to their PAP therapy, potentially improving sleep and overall health.
What could go wrong
The trial is small (50 participants) and early, so results may not apply to everyone. The wearable device may not be as accurate as medical-grade equipment, and the program's success depends on participants' willingness to use it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • VA Greater Los Angeles Healthcare System

    North Hills, California, 91343, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.